AVIR
Atea Pharmaceuticals Inc
5.20$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | – | – | – | |
| – | – | 78.2% | 0.0% | 0.1% | – | – | – | |
| – | – | 21.8% | 100.0% | -0.1% | – | – | – | |
| – | – | 78.2% | 47.6% | 42.6% | – | – | – | |
| – | – | 44.5% | 13.0% | 25.3% | – | – | – | |
| – | – | 44.5% | 60.6% | 68.0% | – | – | – | |
| – | – | -22.7% | 39.4% | -68.0% | – | – | – | |
| – | – | 0.2% | 0.1% | 5.8% | – | – | – | |
| – | – | -22.5% | 39.4% | -62.2% | – | – | – | |
| – | – | -0.2% | 5.0% | -1.9% | – | – | – | |
| – | – | -22.5% | 34.5% | -60.3% | – | – | – | |
| – | – | -22.6% | 39.4% | -67.8% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.